Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Vivet Therapeutics’ Dr Gloria Gonzalez-Aseguinolaza receives the Rosalind Franklin Society Special Award in Science
Vivet Therapeutics’ Dr Gloria Gonzalez-Aseguinolaza receives the Rosalind Franklin Society Special Award in Science
The award was appointed to Dr Gloria Gonzalez-Aseguinolaza for her work in advancing cell and gene therapies
Mogrify appoints Dr Jonathan Appleby as Chief Scientific Officer
Mogrify appoints Dr Jonathan Appleby as Chief Scientific Officer
Dr Appleby has extensive experience in the development and commercialisation of both conventional and advanced therapeutics
Cellular Origins appoints Geoffrey Hodge as Non-Executive Director
Cellular Origins appoints Geoffrey Hodge as Non-Executive Director
Geoff will contribute to the company's commercial growth efforts while also shaping the future direction of Cellular Origins
Quell Therapeutics Appoints Experienced Biopharma Leader Luke Beshar as Independent Chair of its Board of Directors
Quell Therapeutics Appoints Experienced Biopharma Leader Luke Beshar as Independent Chair of its Board of Directors
Luke brings more than 35 years of experience to the role, and has been non-executive director of a range of large biopharmaceutical companies
etherna appoints Antonin de Fougerolles as new Chairperson
etherna appoints Antonin de Fougerolles as new Chairperson
Tony has extensive experience in the development of novel therapeutic modalities, such as RNAis and modified mRNAs for vaccinations
Selkirk Pharma appoints Colleen Dixon as CEO
Selkirk Pharma appoints Colleen Dixon as CEO
Colleen has more than 30 years of experience in the pharmaceutical industry, and will succeed Patrick Haffey
Newcells Biotech appoints Emile Shaffu as Director of Sales
Newcells Biotech appoints Emile Shaffu as Director of Sales
Emile will work with Newcells to expand its global presence, as well as boost its customer service capabilities
H.E.L Group appoints Yih-Shing Duh as Chief Scientific Advisor
H.E.L Group appoints Yih-Shing Duh as Chief Scientific Advisor
Prof. Duh will continue to assist H.E.L Group in developing its battery calorimeters and lithium ion battery testing protocols
Lonza appoints Wolfgang Wienand as the group’s CEO
Lonza appoints Wolfgang Wienand as the group’s CEO
Wolfgang will lead Lonza as the CDMO continues to push its growth and customer satisfaction
Marchesini Group appoints President Maurizio Marchesini as CEO
Marchesini Group appoints President Maurizio Marchesini as CEO
President Marchesini will focus on investing in technological advances in pharmaceutical manufacturing, as well as globalisation for the group
Asymchem appoints Dr Cheng Yi Chen as CTO of Small Molecules
Asymchem appoints Dr Cheng Yi Chen as CTO of Small Molecules
He will support the group's small molecule sales and offer technical guidance to laboratories and pilot production sites across Europe
CN Bio appoints Lydia Seymour as VP of People and Culture
CN Bio appoints Lydia Seymour as VP of People and Culture
Lydia will work to enhance the company's workplace culture, whilst also supporting the career development and general wellbeing of employees
Actylis appoints Scott Thomson as CEO
Actylis appoints Scott Thomson as CEO
Scott will endeavour to globally expand the company's integrated manufacturing and sourcing strategy
Enterprise Therapeutics appoints new as Chief Medical Officer and Non-Executive Director
Enterprise Therapeutics appoints new as Chief Medical Officer and Non-Executive Director
The appointments will help push the company's lead asset through Phase II trials
Onyx Scientific aims for European growth with new BD hire
Onyx Scientific aims for European growth with new BD hire
Leading small molecule CDMO Onyx Scientific has its sights set on European-wide commercial expansion with the new appointment of Courtnie Thomas Wilks as Business Development...
AES Clean Technology appoints Chris Miller as CEO
AES Clean Technology appoints Chris Miller as CEO
Miller will champion the company’s growth whilst encouraging the development of industry innovations
Asymchem hires Franck Mevellec as Senior Director of business development
Asymchem hires Franck Mevellec as Senior Director of business development
Franck has more than 20 years of industry experience, holding key positions in sales, R&D and portfolio management
Exonate appoints Dr Rafiq Hasan as Non-Executive Director
Exonate appoints Dr Rafiq Hasan as Non-Executive Director
Dr Hasan will assist the company in developing its lead candidate, as well as strengthening its commercial strategy
Rentschler Biopharma appoints Patrick Meyer as Global Head BD Sales and Alliance Management
Rentschler Biopharma appoints Patrick Meyer as Global Head BD Sales and Alliance Management
Rentschler Biopharma SE announces that Patrick Meyer, Ph.D., has been promoted to Global Head BD Sales and Alliance Management within the business development team, effective...
Refeyn announces appointment of Fiona Coats as Chief Marketing Officer
Refeyn announces appointment of Fiona Coats as Chief Marketing Officer
Fiona comes from Sartorius, and will drive the company's growth and solidify its market position
Closed Loop Medicine appoints Paul Johnson as Non-Executive Director
Closed Loop Medicine appoints Paul Johnson as Non-Executive Director
Paul will work with the company to drive forward its commercialisation strategy for its portfolio of precision care solutions
Sphere Fluidics appoints Curtis Nicholson as Director of Sales: EMEA
Sphere Fluidics appoints Curtis Nicholson as Director of Sales: EMEA
Curtis will lead the expansion of the company's sales and customer support activities
Engitix appoints Matthew Edwards as SVP Discovery and Emma Huang as VP Data Sciences
Engitix appoints Matthew Edwards as SVP Discovery and Emma Huang as VP Data Sciences
The company welcomes the two novel appointments, who will assist in enhancing the drug discovery strategy
Stablepharma welcomes Sir Jonathan Van-Tam to its advisory board
Stablepharma welcomes Sir Jonathan Van-Tam to its advisory board
The company will use Prof. Van-Tam's health expertise to advance its vaccination projects
Previous
1
2
3
4
(current)
5
6
7
…
139
Next
Trending Articles
Upcoming event
CPhI North America
20–22 May 2025 | Exhibition | Pennsylvania, US
See all